ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

SRPT Sarepta Therapeutics Inc New

138,65
11,99 (9,47%)
02 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Sarepta Therapeutics Inc New SRPT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
11,99 9,47% 138,65 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
127,06 126,50 131,61 130,90 126,66
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202422:05BWSarepta Therapeutics Announces First Quarter 2024 Financial..
01.5.202400:38BWSarepta Therapeutics Announces Inducement Grants Under..
24.4.202414:30BWSarepta Therapeutics to Announce First Quarter 2024..
29.3.202421:00BWSarepta Therapeutics Announces Inducement Grants Under..
08.3.202423:38EDGAR2Form 144 - Report of proposed sale of securities
07.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202423:34EDGAR2Form 144 - Report of proposed sale of securities
04.3.202414:30BWSarepta Therapeutics to Present at Upcoming Investor..
02.3.202401:55EDGAR2Form 144 - Report of proposed sale of securities
02.3.202401:42EDGAR2Form 144 - Report of proposed sale of securities
01.3.202422:47EDGAR2Form 144 - Report of proposed sale of securities
01.3.202400:16BWSarepta Therapeutics Announces Inducement Grants Under..
29.2.202415:00BWSarepta Therapeutics Announces Call for Applications for the..
28.2.202422:05BWSarepta Therapeutics Announces Fourth Quarter and Full-Year..
21.2.202414:30BWSarepta Therapeutics to Announce Fourth Quarter and..
16.2.202413:00BWSarepta Therapeutics Announces U.S. FDA Acceptance of an..
13.2.202419:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10.2.202400:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01.2.202400:29BWSarepta Therapeutics Announces Inducement Grants Under..
29.1.202413:00BWSarepta Therapeutics Announces Positive Data from Part B of..
16.1.202415:02BWSarepta Therapeutics Initiates Screening in EMERGENE, a..
08.1.202418:08EDGAR2Form 8-K - Current report
08.1.202417:55BWSarepta Therapeutics Reports Preliminary* Fourth Quarter and..
02.1.202414:30BWSarepta Therapeutics to Present at the 42nd Annual J.P...
30.12.202300:27BWSarepta Therapeutics Announces Inducement Grants Under..
22.12.202314:00BWSarepta Therapeutics Submits Efficacy Supplement to Expand..
06.12.202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202300:34BWSarepta Therapeutics Announces Inducement Grants Under..
21.11.202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.11.202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.11.202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.11.202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.11.202313:30BWSarepta Therapeutics to Present at the UBS Biopharma..
01.11.202321:05BWSarepta Therapeutics Announces Third Quarter 2023 Financial..
01.11.202321:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.11.202300:02BWSarepta Therapeutics Announces Inducement Grants Under..
30.10.202322:17DJNSarepta Therapeutics to Request Expansion of Elevidys to All..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock